|Number of samples:||13|
|Release date:||Dec 23 2013|
|Last update date:||Oct 18 2018|
|Diseases:||Hyperphagia, Neoplasms, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|
|Dataset link||Targeting transcriptional dependencies in cancer using a covalent CDK7 inhibitor (ChIP-Seq)|
Jurkat, MM1S, Loucy, and HeLa (WT and Dox-inducible CDK7 mutant) cells were treated with various drugs including a covalent inhibitor of CDK7 (CDK7-IN-1), a reversible inhibitor of CDK7 (CDK7-IN-1), Flavopiridol, Actinomycin D, and DMSO controls. Replicates are annotated.
Richard A Young